Organ on a chip technology enables functional units of living human tissues and organs to be replicated on a microchip, providing a human-relevant test system for drug development and safety testing. Organ on chips allow researchers to study complex physiological processes in living cells outside the body in a controlled laboratory environment. They can replicate the activities, mechanics and physiological response of organs and organ systems such as the lung, heart, liver, intestine, kidney, and skin. This helps in understanding disease progression and related pathophysiological mechanisms.
The global Organ On A Chip Market is estimated to be valued at US$ 228.24 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of organ on chip technology in drug development and safety testing is a major key trend driving the growth of the organ on chip market. Organ on chips allow researchers to replicate human physiology and diseases with high accuracy and reliability, enabling more predictive preclinical research and testing of drug candidates and substances. This is helping pharmaceutical companies to reduce costs associated with drug development by eliminating non-effective candidates at an early stage, before clinical trials. By 2024, over 80% of pharmaceutical companies are expected to utilize organ on chip platforms for research and drug development. This is expected to significantly drive the demand for organ on chips over the forecast period.
Segment Analysis
The organ on a chip market is dominated by the lung on a chip segment. This is because lung is one of the most complex organs which mimic breathing and alveolar lung tissue barrier functions. The lung on a chip provides a more reliable alternative to animal testing and helps in developing better drugs for respiratory diseases.
Key Takeaways
The Global Organ On A Chip Market Size is expected to witness high growth over the forecast period of 2023-2030. The global Organ On A Chip Market is estimated to be valued at US$ 228.24 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030.
Regional analysis: North America accounted for the largest share of the organ on a chip market in 2024 due to high adoption of organ on a chip technologies for drug screening and presence of key players in the US. However, Asia Pacific is expected to grow at the fastest pace during the forecast period supported by rising R&D investments by governments of various countries such as China & India for developing indigenous organ chip technologies.
Key players: Key players operating in the organ on a chip market are Ball Corporation, Crown Holdings, Inc., Trivium Packaging B.V., Mauser Packaging Solutions, CCL Containers.
Get more insights on this topic:
https://www.dailyprbulletin.com/organ-on-a-chip-market-size/
Check below trending articles related to this topic:
Explore more trending article related to this topic:
https://masstamilan.in/shipbuilding-an-ancient-industry-still-dominating-global-trade/
Market HighlightsAccording to MRFR analysis, Organ-On-a-Chip Market is expected to register a CAGR of 53% during the forecast period of 2019 to 2025 and was valued at USD 51.3 Million in 2018.Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate crucial physiological functions of body organs.
These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8498The global organ-on-a-chip market is growing owing to various reasons, such as an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the availability of advanced models of OOCs in the market.
The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The organ-on-a-chip market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.Asia-Pacific is the fastest-growing region in the market.
This is mainly due to the increased application of OOCs for drug screening for the treatment of various chronic diseases and a supportive regulatory framework in Asia-Pacific.
Such favorable factors are expected to boost market growth during the forecast period.The organ-on-a-chip market in the Middle East & Africa has been divided into the Middle East and Africa.SegmentationThe global organ-on-a-chip market has been segmented based on organ type, application, and end-user.The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.The market based on application has been branched into drug discovery, toxicology research, and others.
